TITLE:
A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

CONDITION:
Locally Advanced or Metastatic Adenoca of the Biliary Tract

INTERVENTION:
OSI-7904L

SUMMARY:

      Multi-center, randomized Phase II study to evaluate the efficacy and safety of
      OSI-7904Lversus 5 FU/LV in biliary tract cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

        Documented locally advanced or metastatic adenocarcinoma of the biliary tract; Adequate
        bone marrow, hepatic and renal function; Bilirubin <= 1.5 times the upper limit of normal;
        Age 18 years or older; Predicted life expectancy 12 weeks or more; Prior surgery and
        radiation therapy permitted provided patient has recovered adequately; At least 1 target
        lesion >= 20 mm (or >= 10 mm on spiral CT-scan); ECOG Performance Status 0-2; No prior
        chemotherapy for locally advanced or metastatic disease. Adjuvant/neo-adjuvant permitted
        if therapy was completed at least 12 months prior to study entry;

        Exclusion Criteria:

        Concurrent anticancer therapy while on study; History of other malignancy within the past
        3 years except basal or squamous cell carcinoma or in situ cervical cancer; Symptomatic
        brain metastases which are not stable or have required radiation in the past 28 days;
      
